Symbol="CYCC"
AssetType="Common Stock"
Name="Cyclacel Pharmaceuticals Inc"
Description="Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops drugs for the treatment of cancer and other proliferative diseases. The company is headquartered in Berkeley Heights, New Jersey."
CIK="1130166"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="200 CONNELL DRIVE, SUITE 1500, BERKELEY HEIGHTS, NJ, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="5593700"
EBITDA="-28529000"
PERatio="None"
PEGRatio="0"
BookValue="0.406"
DividendPerShare="0"
DividendYield="0"
EPS="-1.91"
RevenuePerShareTTM="0.03"
ProfitMargin="0"
OperatingMarginTTM="-76.57"
ReturnOnAssetsTTM="-0.689"
ReturnOnEquityTTM="-1.345"
RevenueTTM="373000"
GrossProfitTTM="-455000"
DilutedEPSTTM="-1.91"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="12.25"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="74.57"
PriceToBookRatio="0.336"
EVToRevenue="6.1"
EVToEBITDA="0.58"
Beta="1.078"
num_52WeekHigh="1.77"
num_52WeekLow="0.42"
num_50DayMovingAverage="0.612"
num_200DayMovingAverage="0.736"
SharesOutstanding="12539200"
DividendDate="2020-04-15"
ExDividendDate="None"
symbol="CYCC"
open="0.43"
high="0.50"
low="0.41"
price="0.45"
volume="75831.00"
latest_trading_day="2023-08-18"
previous_close="0.43"
change="0.02"
change_percent="3.7442%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="60"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="40"
Volume_recent_avg="67281"
Change_recent_avg="-0.01"
Delta_recent_avg="0.06"
Variance_recent_avg="0.03"
Change_ratio_recent_avg="-1.31"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="40"
Aroon_momentum_negative="60"
image_negative_thumbnail_id_1="1157"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0191.jpeg"
image_negative_thumbnail_id_2="132"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0044.jpeg"
image_neutral_thumbnail_id_1="536"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0063.jpeg"
image_neutral_thumbnail_id_2="432"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Neutral_Landscape_0019.jpeg"
image_positive_thumbnail_id_1="704"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0004.jpeg"
image_positive_thumbnail_id_2="952"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0114.jpeg"
image_professor_thumbnail_id_1="1173"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0007.jpeg"
image_professor_thumbnail_id_2="1194"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0028.jpeg"
